Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

Implications and mechanisms of O-GlcNAcylation in cancer therapy resistance

Hongwei Gao1, Binyuan Ma2, Youli Zhao1

  • 1Laboratory Medicine Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.

Tumori
|December 24, 2024
PubMed

Insights

O-linked-N-acetylglucosaminylation (O-GlcNAcylation) impacts cancer therapy tolerance. Understanding O-GlcNAcylation mechanisms may reveal new strategies to improve cancer treatment efficacy.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • O-linked-N-acetylglucosaminylation (O-GlcNAcylation) is a crucial post-translational modification.
  • It regulates fundamental cellular processes like gene transcription and metabolism.
  • While its role in tumorigenesis is known, its impact on cancer therapy tolerance is unclear.

Purpose of the Study:

  • To review current evidence on O-GlcNAcylation's role in cancer therapy responsiveness.
  • To explore mechanisms linking O-GlcNAcylation dysregulation to therapy efficacy.
  • To assess O-GlcNAcylation as a potential sensitizer for cancer therapies.

Main Methods:

  • Literature review of recent studies on O-GlcNAcylation and cancer therapy.
  • Analysis of proposed molecular mechanisms.
  • Discussion of therapeutic implications.

Main Results:

  • O-GlcNAcylation significantly influences cancer cell response to various therapies.
  • Dysregulated O-GlcNAcylation can either promote or inhibit treatment outcomes.
  • Specific pathways involving O-GlcNAcylation are identified as critical for therapy efficacy.

Conclusions:

  • O-GlcNAcylation plays a complex role in cancer therapy tolerance.
  • Targeting O-GlcNAcylation pathways presents a promising strategy to enhance cancer treatment.
  • Further research is needed to fully elucidate and exploit O-GlcNAcylation in clinical settings.
Keywords:
O-GlcNAcylationOGTanticancer therapychemoresistancedrug resistancepost-translational modification

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K
Glycan Node Analysis: A Bottom-up Approach to Glycomics11:36

Glycan Node Analysis: A Bottom-up Approach to Glycomics

Published on: May 22, 2016

10.3K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K